Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $115.2M
Liabilities Breakdown FY2014
Total Liabilities: $95.8M
Asset Breakdown
Total Assets: $115.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.1M | 20.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.8M | 1.6% |
| Goodwill | $15.5M | 13.5% |
| Intangible Assets | $47.3M | 41.1% |
| Other Assets | $27.5M | 23.8% |
Liabilities Breakdown
Total Liabilities: $95.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.2M | 2.3% |
| Long-Term Debt | $27.2M | 28.3% |
| Other Liabilities | $66.5M | 69.4% |